Scenario 3: Preservation of renal function with early use of TAF in CHB patients with prevailing eGFR

thumb

Dr. Douglas Dieterich

Director,
Institute of Liver Medicine,
Mount Sinai Health System ,
Professor of Medicine,
Division of Liver Diseases,
Icahn School of Medicine,
Mount Sinai,
New Yok, United State
thumb

Dr. I-Cheng Lee

The Division of Gastroenterology & Hepatology,
Taipei Veterans General Hospital, 
Taiwan

TAF
CHB
CHRONIC HEPATITIS B
Q & A

1.Will you proactively identify and monitor the risk factors for renal function deterioration?

2.Do you agree TAF is a safe and effective CHB treatment with high potency?

3.Do you agree TAF is a simplified treatment? ​​​​​​​

4.Do you agree TAF can provide substantial recovery of the renal function after switching? ​​​​​​​

5.Do you agree early switching to TAF can help safeguard the renal health of CHB patients? Will you consider an early switch?

6.Will you start/switch TAF in patients with risk of deteriorating renal function?

Your answers will be used for educational purposes only. Personal information will not be disclosed to any third parties.
Related Articles

HCC incidence reduced with HBsAg seroclearance VS. Viral suppression in cirrhotic CHB patients

Glossary: AFP: Alpha-fetoprotein; aHR: Adjusted hazard ratio; ALT: Alanine aminotransferase; cccDNA: Close covalent circular deoxyribonucleic acid; CHB: Chronic hepatitis B; cHR: Crude hazard ratio; CI: Confidence interval; FIB-4: Fibrosis-4 index; HBsAg: Hepatitis B surface antigen; HBV: Hepatiti
GASTROENTEROLOGY & HEPATOLOGY
10 Nov 2022

TAF for pregnant Chinese women with active CHB

Glossary: AE: Adverse event; ALT: Alanine aminotransferase; CHB: Chronic hepatitis B; HBeAg: Hepatitis B e-antigen; HBsAg: Hepatitis B surface antigen; HBV: Heaptitis B virus; DNA: Deoxyribonucleic acid; QD: Once a day; TAF: Tenofovir alafenamide; TDF: Tenofovir disoproxil fumarate; WHO: World Hea
GASTROENTEROLOGY & HEPATOLOGY OBSTETRICS & GYNECOLOGY
08 Nov 2022

The pharmacokinetics, safety, and antiviral efficacy of taf in children and adolescent with CHB

Glossary: AASLD: American Association for the Study of Liver Diseases; ALT: Alanine aminotransferase; BMD: Bone mineral density; CHB: Chronic hepatitis B; CLCr: Creatinine clearance; HBeAg: Hepatitis B e-antigen; HBV: Hepatitis B virus; DNA: Deoxyribonucleic acid; PBO: Placebo; QD: Once a day; sCr
GASTROENTEROLOGY & HEPATOLOGY PEDIATRICS
08 Nov 2022

The efficacy and safety of TAF vs. TDF in treatment-naïve CHB patients

Glossary: AASLD: American Associatioin fo the Study of Liver Diseases; ALT: Alanine aminotransferase; CHB: Chronic hepatitis B; DNA: Deoxyribonucleic acid; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; PS: Propensity score; sCr:
GASTROENTEROLOGY & HEPATOLOGY
08 Nov 2022

Switch to TAF for improved efficacy and bone density in CHB patients

Glossary: ALT: Alanine aminotransferase; aOR: Adjusted odd ratio; BMD: Bone mineral density; CHB: Chronic hepatitis B; CI: Confidence interval; CKD: Chronic kidney disease; CR: Complete response; DNA: Deoxyribonucleic acid; eGFR: Estimated glomerular filtration rate; ETV: Entecavir; HBV: Hepatitis
GASTROENTEROLOGY & HEPATOLOGY
08 Nov 2022

The risk of HCC in CHB patients receiving TDF- or ETV-based regimens

Glossary: aHR: Adjusted hazard ratio; CHB: Chronic hepatitis B; CI: Confidence interval; ETV: Entecavir; HBeAg: Hepatitis B e-antigen; HCC: Hematocellular carcinoma; HR: Hazard ratio; IPD: Individual patient data; TDF: Tenofovir disoproxil fumarate

GASTROENTEROLOGY & HEPATOLOGY
07 Nov 2022